Coeptis Therapeutics Holdings, Inc.
COEP
$14.64
-$0.11-0.75%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 92.10% | 314.73% | -63.73% | -19.41% | -52.07% |
| Total Receivables | -84.30% | -- | -- | -- | -45.40% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 176.80% | 58.10% | 114.57% | 9.18% | 20.89% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 85.59% | 237.08% | -39.92% | -15.79% | -47.57% |
|
|
|||||
| Total Current Assets | 85.59% | 237.08% | -39.92% | -15.79% | -47.57% |
| Net Property, Plant & Equipment | -44.78% | -39.60% | -35.54% | 99.01% | 76.82% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -46.00% | -42.70% | 784.35% | 735.97% |
| Total Assets | 190.38% | 245.46% | 94.89% | 91.74% | -41.33% |
|
|
|||||
| Total Accounts Payable | -19.70% | -17.95% | -10.56% | 135.31% | 224.19% |
| Total Accrued Expenses | -46.02% | -16.22% | 32.54% | 30.90% | 211.77% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -26.04% | -15.57% | 21.44% | 31.88% | -15.91% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 23.43% | 31.40% | 51.01% | 53.94% | 44.23% |
|
|
|||||
| Total Current Liabilities | 23.43% | 31.40% | 51.01% | 53.94% | 44.23% |
| Long-Term Debt | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -69.12% | -69.12% | -69.12% | 316.33% | 316.33% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -30.42% | -67.63% | -35.53% | -14.88% | -66.21% |
| Total Liabilities | 13.37% | 18.97% | 34.18% | 43.04% | -3.38% |
|
|
|||||
| Common Stock & APIC | 11.29% | 14.43% | 12.33% | 16.08% | 26.88% |
| Retained Earnings | -13.49% | -12.50% | -12.45% | -13.90% | -21.73% |
| Treasury Stock & Other | 103.10% | 95.45% | 55.48% | 16.00% | -- |
| Total Common Equity | 1,477.27% | 668.00% | 291.30% | 154.88% | -117.78% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1,477.27% | 668.00% | 291.30% | 154.88% | -117.78% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 642.87% | -- | -- | -- | -- |
| Total Equity | 2,383.17% | 754.30% | 375.09% | 163.22% | -112.46% |
|
|
|||||